Table of Content

1. Preface
1.1. Objectives of the Study
1.2. Market Segmentation & Coverage
1.3. Years Considered for the Study
1.4. Currency & Pricing
1.5. Language
1.6. Limitations
1.7. Assumptions
1.8. Stakeholders

2. Research Methodology
2.1. Define: Research Objective
2.2. Determine: Research Design
2.3. Prepare: Research Instrument
2.4. Collect: Data Source
2.5. Analyze: Data Interpretation
2.6. Formulate: Data Verification
2.7. Publish: Research Report
2.8. Repeat: Report Update

3. Executive Summary

4. Market Overview
4.1. Introduction
4.2. Dementia Drugs Market, by Region

5. Market Insights
5.1. Market Dynamics
5.1.1. Drivers
5.1.1.1. Growing geriatric population base
5.1.1.2. Increase in prevalence of Alzheimer disease
5.1.1.3. Government funding & awareness programs for Alzheimer disease
5.1.2. Restraints
5.1.2.1. High costs of research and drug development
5.1.3. Opportunities
5.1.3.1. Continuous growth in popularity of online pharmacy services due to providing safe and reliable access to medication
5.1.3.2. Advancement of new drugs and treatments
5.1.3.3. Advancing therapeutic and biomarker development for Alzheimer’s and related dementias created funding opportunities
5.1.4. Challenges
5.1.4.1. Complex pathology and etiology and no biomarkers for early detection of the disease
5.2. Market Segmentation Analysis
5.3. Market Trend Analysis
5.4. Cumulative Impact of High Inflation
5.5. Porter’s Five Forces Analysis
5.5.1. Threat of New Entrants
5.5.2. Threat of Substitutes
5.5.3. Bargaining Power of Customers
5.5.4. Bargaining Power of Suppliers
5.5.5. Industry Rivalry
5.6. Value Chain & Critical Path Analysis
5.7. Regulatory Framework

6. Dementia Drugs Market, by Indications
6.1. Introduction
6.2. Alzheimer’s Disease
6.3. Lewy Body Dementia
6.4. Parkinsons Disease Dementia
6.5. Vascular Dementia

7. Dementia Drugs Market, by Drug Class
7.1. Introduction
7.2. Cholinesterase Inhibitors
7.3. Glutamate Inhibitors
7.4. MAO Inhibitors

8. Americas Dementia Drugs Market
8.1. Introduction
8.2. Argentina
8.3. Brazil
8.4. Canada
8.5. Mexico
8.6. United States

9. Asia-Pacific Dementia Drugs Market
9.1. Introduction
9.2. Australia
9.3. China
9.4. India
9.5. Indonesia
9.6. Japan
9.7. Malaysia
9.8. Philippines
9.9. Singapore
9.10. South Korea
9.11. Taiwan
9.12. Thailand
9.13. Vietnam

10. Europe, Middle East & Africa Dementia Drugs Market
10.1. Introduction
10.2. Denmark
10.3. Egypt
10.4. Finland
10.5. France
10.6. Germany
10.7. Israel
10.8. Italy
10.9. Netherlands
10.10. Nigeria
10.11. Norway
10.12. Poland
10.13. Qatar
10.14. Russia
10.15. Saudi Arabia
10.16. South Africa
10.17. Spain
10.18. Sweden
10.19. Switzerland
10.20. Turkey
10.21. United Arab Emirates
10.22. United Kingdom

11. Competitive Landscape
11.1. FPNV Positioning Matrix
11.2. Market Share Analysis, By Key Player
11.3. Competitive Scenario Analysis, By Key Player

12. Competitive Portfolio
12.1. Key Company Profiles
12.1.1. Anavex Life Sciences Corp.
12.1.2. AstraZeneca PLC
12.1.3. Aurobindo Pharma Limited
12.1.4. Biogen Inc.
12.1.5. Eisai Co., Ltd
12.1.6. Eli Lilly and Company
12.1.7. F. Hoffmann-La Roche AG
12.1.8. Forest Laboratories, Inc.
12.1.9. Janssen Global Services, LLC
12.1.10. Merck & Co., Inc.
12.1.11. Novartis AG
12.1.12. Pfizer, Inc.
12.1.13. Quidel Corporation
12.1.14. Sanofi S.A.
12.1.15. Teva Pharmaceutical Industries Ltd.
12.1.16. Valeant Pharmaceuticals International, Inc.
12.1.17. Zydus Cadila
12.2. Key Product Portfolio

13. Appendix
13.1. Discussion Guide
13.2. License & Pricing



List of Figures

FIGURE 1. DEMENTIA DRUGS MARKET RESEARCH PROCESS
FIGURE 2. DEMENTIA DRUGS MARKET SIZE, 2023 VS 2030
FIGURE 3. DEMENTIA DRUGS MARKET SIZE, 2018-2030 (USD MILLION)
FIGURE 4. DEMENTIA DRUGS MARKET SIZE, BY REGION, 2023 VS 2030 (%)
FIGURE 5. DEMENTIA DRUGS MARKET SIZE, BY REGION, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 6. DEMENTIA DRUGS MARKET DYNAMICS
FIGURE 7. DEMENTIA DRUGS MARKET SIZE, BY INDICATIONS, 2023 VS 2030 (%)
FIGURE 8. DEMENTIA DRUGS MARKET SIZE, BY INDICATIONS, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 9. DEMENTIA DRUGS MARKET SIZE, BY DRUG CLASS, 2023 VS 2030 (%)
FIGURE 10. DEMENTIA DRUGS MARKET SIZE, BY DRUG CLASS, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 11. AMERICAS DEMENTIA DRUGS MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
FIGURE 12. AMERICAS DEMENTIA DRUGS MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 13. UNITED STATES DEMENTIA DRUGS MARKET SIZE, BY STATE, 2023 VS 2030 (%)
FIGURE 14. UNITED STATES DEMENTIA DRUGS MARKET SIZE, BY STATE, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 15. ASIA-PACIFIC DEMENTIA DRUGS MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
FIGURE 16. ASIA-PACIFIC DEMENTIA DRUGS MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 17. EUROPE, MIDDLE EAST & AFRICA DEMENTIA DRUGS MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
FIGURE 18. EUROPE, MIDDLE EAST & AFRICA DEMENTIA DRUGS MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 19. DEMENTIA DRUGS MARKET, FPNV POSITIONING MATRIX, 2023
FIGURE 20. DEMENTIA DRUGS MARKET SHARE, BY KEY PLAYER, 2023

List of Tables

TABLE 1. DEMENTIA DRUGS MARKET SEGMENTATION & COVERAGE
TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2018–2023
TABLE 3. DEMENTIA DRUGS MARKET SIZE, 2018-2030 (USD MILLION)
TABLE 4. GLOBAL DEMENTIA DRUGS MARKET SIZE, BY REGION, 2018-2030 (USD MILLION)
TABLE 5. DEMENTIA DRUGS MARKET SIZE, BY INDICATIONS, 2018-2030 (USD MILLION)
TABLE 6. DEMENTIA DRUGS MARKET SIZE, BY ALZHEIMER’S DISEASE, BY REGION, 2018-2030 (USD MILLION)
TABLE 7. DEMENTIA DRUGS MARKET SIZE, BY LEWY BODY DEMENTIA, BY REGION, 2018-2030 (USD MILLION)
TABLE 8. DEMENTIA DRUGS MARKET SIZE, BY PARKINSONS DISEASE DEMENTIA, BY REGION, 2018-2030 (USD MILLION)
TABLE 9. DEMENTIA DRUGS MARKET SIZE, BY VASCULAR DEMENTIA, BY REGION, 2018-2030 (USD MILLION)
TABLE 10. DEMENTIA DRUGS MARKET SIZE, BY DRUG CLASS, 2018-2030 (USD MILLION)
TABLE 11. DEMENTIA DRUGS MARKET SIZE, BY CHOLINESTERASE INHIBITORS, BY REGION, 2018-2030 (USD MILLION)
TABLE 12. DEMENTIA DRUGS MARKET SIZE, BY GLUTAMATE INHIBITORS, BY REGION, 2018-2030 (USD MILLION)
TABLE 13. DEMENTIA DRUGS MARKET SIZE, BY MAO INHIBITORS, BY REGION, 2018-2030 (USD MILLION)
TABLE 14. AMERICAS DEMENTIA DRUGS MARKET SIZE, BY INDICATIONS, 2018-2030 (USD MILLION)
TABLE 15. AMERICAS DEMENTIA DRUGS MARKET SIZE, BY DRUG CLASS, 2018-2030 (USD MILLION)
TABLE 16. AMERICAS DEMENTIA DRUGS MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
TABLE 17. ARGENTINA DEMENTIA DRUGS MARKET SIZE, BY INDICATIONS, 2018-2030 (USD MILLION)
TABLE 18. ARGENTINA DEMENTIA DRUGS MARKET SIZE, BY DRUG CLASS, 2018-2030 (USD MILLION)
TABLE 19. BRAZIL DEMENTIA DRUGS MARKET SIZE, BY INDICATIONS, 2018-2030 (USD MILLION)
TABLE 20. BRAZIL DEMENTIA DRUGS MARKET SIZE, BY DRUG CLASS, 2018-2030 (USD MILLION)
TABLE 21. CANADA DEMENTIA DRUGS MARKET SIZE, BY INDICATIONS, 2018-2030 (USD MILLION)
TABLE 22. CANADA DEMENTIA DRUGS MARKET SIZE, BY DRUG CLASS, 2018-2030 (USD MILLION)
TABLE 23. MEXICO DEMENTIA DRUGS MARKET SIZE, BY INDICATIONS, 2018-2030 (USD MILLION)
TABLE 24. MEXICO DEMENTIA DRUGS MARKET SIZE, BY DRUG CLASS, 2018-2030 (USD MILLION)
TABLE 25. UNITED STATES DEMENTIA DRUGS MARKET SIZE, BY INDICATIONS, 2018-2030 (USD MILLION)
TABLE 26. UNITED STATES DEMENTIA DRUGS MARKET SIZE, BY DRUG CLASS, 2018-2030 (USD MILLION)
TABLE 27. UNITED STATES DEMENTIA DRUGS MARKET SIZE, BY STATE, 2018-2030 (USD MILLION)
TABLE 28. ASIA-PACIFIC DEMENTIA DRUGS MARKET SIZE, BY INDICATIONS, 2018-2030 (USD MILLION)
TABLE 29. ASIA-PACIFIC DEMENTIA DRUGS MARKET SIZE, BY DRUG CLASS, 2018-2030 (USD MILLION)
TABLE 30. ASIA-PACIFIC DEMENTIA DRUGS MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
TABLE 31. AUSTRALIA DEMENTIA DRUGS MARKET SIZE, BY INDICATIONS, 2018-2030 (USD MILLION)
TABLE 32. AUSTRALIA DEMENTIA DRUGS MARKET SIZE, BY DRUG CLASS, 2018-2030 (USD MILLION)
TABLE 33. CHINA DEMENTIA DRUGS MARKET SIZE, BY INDICATIONS, 2018-2030 (USD MILLION)
TABLE 34. CHINA DEMENTIA DRUGS MARKET SIZE, BY DRUG CLASS, 2018-2030 (USD MILLION)
TABLE 35. INDIA DEMENTIA DRUGS MARKET SIZE, BY INDICATIONS, 2018-2030 (USD MILLION)
TABLE 36. INDIA DEMENTIA DRUGS MARKET SIZE, BY DRUG CLASS, 2018-2030 (USD MILLION)
TABLE 37. INDONESIA DEMENTIA DRUGS MARKET SIZE, BY INDICATIONS, 2018-2030 (USD MILLION)
TABLE 38. INDONESIA DEMENTIA DRUGS MARKET SIZE, BY DRUG CLASS, 2018-2030 (USD MILLION)
TABLE 39. JAPAN DEMENTIA DRUGS MARKET SIZE, BY INDICATIONS, 2018-2030 (USD MILLION)
TABLE 40. JAPAN DEMENTIA DRUGS MARKET SIZE, BY DRUG CLASS, 2018-2030 (USD MILLION)
TABLE 41. MALAYSIA DEMENTIA DRUGS MARKET SIZE, BY INDICATIONS, 2018-2030 (USD MILLION)
TABLE 42. MALAYSIA DEMENTIA DRUGS MARKET SIZE, BY DRUG CLASS, 2018-2030 (USD MILLION)
TABLE 43. PHILIPPINES DEMENTIA DRUGS MARKET SIZE, BY INDICATIONS, 2018-2030 (USD MILLION)
TABLE 44. PHILIPPINES DEMENTIA DRUGS MARKET SIZE, BY DRUG CLASS, 2018-2030 (USD MILLION)
TABLE 45. SINGAPORE DEMENTIA DRUGS MARKET SIZE, BY INDICATIONS, 2018-2030 (USD MILLION)
TABLE 46. SINGAPORE DEMENTIA DRUGS MARKET SIZE, BY DRUG CLASS, 2018-2030 (USD MILLION)
TABLE 47. SOUTH KOREA DEMENTIA DRUGS MARKET SIZE, BY INDICATIONS, 2018-2030 (USD MILLION)
TABLE 48. SOUTH KOREA DEMENTIA DRUGS MARKET SIZE, BY DRUG CLASS, 2018-2030 (USD MILLION)
TABLE 49. TAIWAN DEMENTIA DRUGS MARKET SIZE, BY INDICATIONS, 2018-2030 (USD MILLION)
TABLE 50. TAIWAN DEMENTIA DRUGS MARKET SIZE, BY DRUG CLASS, 2018-2030 (USD MILLION)
TABLE 51. THAILAND DEMENTIA DRUGS MARKET SIZE, BY INDICATIONS, 2018-2030 (USD MILLION)
TABLE 52. THAILAND DEMENTIA DRUGS MARKET SIZE, BY DRUG CLASS, 2018-2030 (USD MILLION)
TABLE 53. VIETNAM DEMENTIA DRUGS MARKET SIZE, BY INDICATIONS, 2018-2030 (USD MILLION)
TABLE 54. VIETNAM DEMENTIA DRUGS MARKET SIZE, BY DRUG CLASS, 2018-2030 (USD MILLION)
TABLE 55. EUROPE, MIDDLE EAST & AFRICA DEMENTIA DRUGS MARKET SIZE, BY INDICATIONS, 2018-2030 (USD MILLION)
TABLE 56. EUROPE, MIDDLE EAST & AFRICA DEMENTIA DRUGS MARKET SIZE, BY DRUG CLASS, 2018-2030 (USD MILLION)
TABLE 57. EUROPE, MIDDLE EAST & AFRICA DEMENTIA DRUGS MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
TABLE 58. DENMARK DEMENTIA DRUGS MARKET SIZE, BY INDICATIONS, 2018-2030 (USD MILLION)
TABLE 59. DENMARK DEMENTIA DRUGS MARKET SIZE, BY DRUG CLASS, 2018-2030 (USD MILLION)
TABLE 60. EGYPT DEMENTIA DRUGS MARKET SIZE, BY INDICATIONS, 2018-2030 (USD MILLION)
TABLE 61. EGYPT DEMENTIA DRUGS MARKET SIZE, BY DRUG CLASS, 2018-2030 (USD MILLION)
TABLE 62. FINLAND DEMENTIA DRUGS MARKET SIZE, BY INDICATIONS, 2018-2030 (USD MILLION)
TABLE 63. FINLAND DEMENTIA DRUGS MARKET SIZE, BY DRUG CLASS, 2018-2030 (USD MILLION)
TABLE 64. FRANCE DEMENTIA DRUGS MARKET SIZE, BY INDICATIONS, 2018-2030 (USD MILLION)
TABLE 65. FRANCE DEMENTIA DRUGS MARKET SIZE, BY DRUG CLASS, 2018-2030 (USD MILLION)
TABLE 66. GERMANY DEMENTIA DRUGS MARKET SIZE, BY INDICATIONS, 2018-2030 (USD MILLION)
TABLE 67. GERMANY DEMENTIA DRUGS MARKET SIZE, BY DRUG CLASS, 2018-2030 (USD MILLION)
TABLE 68. ISRAEL DEMENTIA DRUGS MARKET SIZE, BY INDICATIONS, 2018-2030 (USD MILLION)
TABLE 69. ISRAEL DEMENTIA DRUGS MARKET SIZE, BY DRUG CLASS, 2018-2030 (USD MILLION)
TABLE 70. ITALY DEMENTIA DRUGS MARKET SIZE, BY INDICATIONS, 2018-2030 (USD MILLION)
TABLE 71. ITALY DEMENTIA DRUGS MARKET SIZE, BY DRUG CLASS, 2018-2030 (USD MILLION)
TABLE 72. NETHERLANDS DEMENTIA DRUGS MARKET SIZE, BY INDICATIONS, 2018-2030 (USD MILLION)
TABLE 73. NETHERLANDS DEMENTIA DRUGS MARKET SIZE, BY DRUG CLASS, 2018-2030 (USD MILLION)
TABLE 74. NIGERIA DEMENTIA DRUGS MARKET SIZE, BY INDICATIONS, 2018-2030 (USD MILLION)
TABLE 75. NIGERIA DEMENTIA DRUGS MARKET SIZE, BY DRUG CLASS, 2018-2030 (USD MILLION)
TABLE 76. NORWAY DEMENTIA DRUGS MARKET SIZE, BY INDICATIONS, 2018-2030 (USD MILLION)
TABLE 77. NORWAY DEMENTIA DRUGS MARKET SIZE, BY DRUG CLASS, 2018-2030 (USD MILLION)
TABLE 78. POLAND DEMENTIA DRUGS MARKET SIZE, BY INDICATIONS, 2018-2030 (USD MILLION)
TABLE 79. POLAND DEMENTIA DRUGS MARKET SIZE, BY DRUG CLASS, 2018-2030 (USD MILLION)
TABLE 80. QATAR DEMENTIA DRUGS MARKET SIZE, BY INDICATIONS, 2018-2030 (USD MILLION)
TABLE 81. QATAR DEMENTIA DRUGS MARKET SIZE, BY DRUG CLASS, 2018-2030 (USD MILLION)
TABLE 82. RUSSIA DEMENTIA DRUGS MARKET SIZE, BY INDICATIONS, 2018-2030 (USD MILLION)
TABLE 83. RUSSIA DEMENTIA DRUGS MARKET SIZE, BY DRUG CLASS, 2018-2030 (USD MILLION)
TABLE 84. SAUDI ARABIA DEMENTIA DRUGS MARKET SIZE, BY INDICATIONS, 2018-2030 (USD MILLION)
TABLE 85. SAUDI ARABIA DEMENTIA DRUGS MARKET SIZE, BY DRUG CLASS, 2018-2030 (USD MILLION)
TABLE 86. SOUTH AFRICA DEMENTIA DRUGS MARKET SIZE, BY INDICATIONS, 2018-2030 (USD MILLION)
TABLE 87. SOUTH AFRICA DEMENTIA DRUGS MARKET SIZE, BY DRUG CLASS, 2018-2030 (USD MILLION)
TABLE 88. SPAIN DEMENTIA DRUGS MARKET SIZE, BY INDICATIONS, 2018-2030 (USD MILLION)
TABLE 89. SPAIN DEMENTIA DRUGS MARKET SIZE, BY DRUG CLASS, 2018-2030 (USD MILLION)
TABLE 90. SWEDEN DEMENTIA DRUGS MARKET SIZE, BY INDICATIONS, 2018-2030 (USD MILLION)
TABLE 91. SWEDEN DEMENTIA DRUGS MARKET SIZE, BY DRUG CLASS, 2018-2030 (USD MILLION)
TABLE 92. SWITZERLAND DEMENTIA DRUGS MARKET SIZE, BY INDICATIONS, 2018-2030 (USD MILLION)
TABLE 93. SWITZERLAND DEMENTIA DRUGS MARKET SIZE, BY DRUG CLASS, 2018-2030 (USD MILLION)
TABLE 94. TURKEY DEMENTIA DRUGS MARKET SIZE, BY INDICATIONS, 2018-2030 (USD MILLION)
TABLE 95. TURKEY DEMENTIA DRUGS MARKET SIZE, BY DRUG CLASS, 2018-2030 (USD MILLION)
TABLE 96. UNITED ARAB EMIRATES DEMENTIA DRUGS MARKET SIZE, BY INDICATIONS, 2018-2030 (USD MILLION)
TABLE 97. UNITED ARAB EMIRATES DEMENTIA DRUGS MARKET SIZE, BY DRUG CLASS, 2018-2030 (USD MILLION)
TABLE 98. UNITED KINGDOM DEMENTIA DRUGS MARKET SIZE, BY INDICATIONS, 2018-2030 (USD MILLION)
TABLE 99. UNITED KINGDOM DEMENTIA DRUGS MARKET SIZE, BY DRUG CLASS, 2018-2030 (USD MILLION)
TABLE 100. DEMENTIA DRUGS MARKET, FPNV POSITIONING MATRIX, 2023
TABLE 101. DEMENTIA DRUGS MARKET SHARE, BY KEY PLAYER, 2023
TABLE 102. DEMENTIA DRUGS MARKET LICENSE & PRICING